Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects

Aisha A. Alsfouk, Ismail M. M. Othman, Manal M. Anwar, Asmaa Saleh and Eman S. Nossier

RSC Adv., 2025, 15, 1407
DOI: 10.1039/D4RA06744D

Design, Synthesis, and Docking Simulation of 1,3,4-Thiadiazolyl-Isoindole Thioglycosides and Hydrazinyl Sugar Analogs as Potential Anticancer Agents Targeting EGFR Kinase

Ahad El-Enazy, Mohamed N. El-Bayaa, Walaa I. El-Sofany, Fahad M. Alminderej, Abuzar E.A.E Albadri and Wael A. El-Sayed

Polycyclic Aromatic Compounds, 2025, 45, 1075
DOI: 10.1080/10406638.2024.2432361

Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights

Yasmin S. Sheta, Marwa T. Sarg, Fatma G. Abdulrahman, Eman S. Nossier and Ebtehal M. Husseiny

Bioorganic Chemistry, 2024, 149, 107471
DOI: 10.1016/j.bioorg.2024.107471

Thiadiazole chitosan conjugates as a novel cosmetic ingredient for rinse-off hair conditioners: design, formulation, characterization and in silico-molecular docking studies

Ahmad E. Mohamed, Walid E. Elgammal, Ahmed G. Ibrahim, Hamdy M. Dawaba, Eman S. Nossier and Aya M. Dawaba

BMC Chemistry, 2025, 19
DOI: 10.1186/s13065-025-01404-6

Pyridine-based glycosides bearing 1,2,4-triazole and their 1,3,4-oxadiazole analogues as potential EGFR and CDK-2 inhibitors: Design, synthesis, antiproliferative activity and in silico studies

Asmaa F. Kassem, Ahmed Younis, Eman S. Nossier, Hanem M. Awad and Wael A. El-Sayed

Journal of Molecular Structure, 2024, 1313, 138741
DOI: 10.1016/j.molstruc.2024.138741

Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors

Danishuddin, M.Z. Malik, M. Kashif, S. Haque and J.J. Kim

SAR and QSAR in Environmental Research, 2024, 35, 325
DOI: 10.1080/1062936X.2024.2345618

Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?

Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, Olorunfemi Oyewole Babalola, Olusola Olalekan Elekofehinti, Babatomiwa Kikiowo, Abayomi Emmanuel Adegboyega, Henry Nnaemeka Ogbonna, Covenant Femi Adeboboye, Ibukun Mary Folorunso, Aderonke Elizabeth Fakayode, Moses Orimoloye Akinjiyan, Sunday Amos Onikanni and Sergey Shityakov

Informatics in Medicine Unlocked, 2023, 41, 101332
DOI: 10.1016/j.imu.2023.101332

A Greener Process for the Synthesis of Base‐Catalyzed Substituted Pyrazoles and Triazolopyrimidines as Prospective Biological Activity

Wafa A. Bawazir, Zahra M. Al‐amshany, Reda M. El‐shishtawy and Ismail M. M. Othman

ChemistrySelect, 2024, 9
DOI: 10.1002/slct.202405011

Tailor‐Made Pyrazolopyridines and Fused Pyrazolopyridines: Recent Updates toward Sustainable Synthesis

Mohabul Alam Mondal and Rina Ghosh

ChemistrySelect, 2024, 9
DOI: 10.1002/slct.202402738

Design, antiproliferative potency, and in silico studies of novel 5-methylfuran-3-yl)thio)-3-phenylquinazolin-4(3H)-one based derivatives as potential EGFR inhibitors

Sara M. Soliman, Adel A.-H. Abdel-Rahman, Eman S. Nossier, Modather F. Hussein, Amr Sabry and Hagar S. El-Hema

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-12140-1

A versatile precursor for one‐pot synthesis of novel azo‐thiazole and thiazole scaffolds as prospective antimicrobial and antioxidant agents

Zahra M. Alamshany, Nada Y. Tashkandi and Ismail M. M. Othman

J Chinese Chemical Soc, 2024, 71, 1309
DOI: 10.1002/jccs.202400173

Novel pyrimidopyridothiazine based derivatives as potential anticancer and antibacterial agents: A step towards design and synthesis of multi-targeted therapeutics

Hagar S. El-Hema, Mohamed F. Mady, Adel A.-H. Abdel-Rahman, Eman S. Nossier, Ahmed F. El-Sayed, Amr Sabry, Murad El-Feky and Mohamed A. Hawata

Journal of Molecular Structure, 2026, 1349, 143790
DOI: 10.1016/j.molstruc.2025.143790

Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives

Eman S. M. Elsenbawy, Zafer S. Alshehri, Nouf A. Babteen, Adel A.-H. Abdel-Rahman, Mai A. El-Manawaty, Eman S. Nossier, Reem K. Arafa and Nasser A. Hassan

Molecules, 2024, 29, 1067
DOI: 10.3390/molecules29051067

New quinazolinone-based heterocyclic compounds as promising antimicrobial agents: development, DNA gyrase B/topoisomerase IV inhibition activity, and in silico computational studies

Aisha A. Alsfouk, Ismail M.M. Othman, Manal M. Anwar, Asmaa Saleh, Nada Y. Tashkandi and Eman S. Nossier

Journal of Molecular Structure, 2025, 1344, 142953
DOI: 10.1016/j.molstruc.2025.142953

Targeting c-Met in Cancer Therapy: Unravelling Structure-activity Relationships and Docking Insights for Enhanced Anticancer Drug Design

Surbhi Singh, Vaibhav Nigam, Shivani Kasana, Balak Das Kurmi, Ghanshyam Das Gupta and Preeti Patel

CTMC, 2025, 25, 409
DOI: 10.2174/0115680266331025241015084546

Design, synthesis, and antimicrobial evaluation of new antipyrine derivatives bearing thiazolopyridazine and pyrazolothiazole scaffolds

Zahra M. Alamshany

Synthetic Communications, 2024, 54, 22
DOI: 10.1080/00397911.2023.2276354

Anticancer activity of new triazolopyrimidine linked coumarin and quinolone hybrids: Synthesis, molecular modeling, TrkA, PI3K/AKT and EGFR inhibition

Rasha Z. Batran, Eman Y. Ahmed, Eman S. Nossier, Hanem M. Awad and Nehad A. Abdel Latif

Journal of Molecular Structure, 2024, 1305, 137790
DOI: 10.1016/j.molstruc.2024.137790

New Thiadiazole‐Triazole Hybrid Glycosides as Potential EGFR and VEGFR‐2 Inhibitors: Synthesis, Anticancer Activity, and Docking Simulation

Ahmed M. Hussein, Walaa I. EL‐Sofany, Fahad M. Alminderej, Abuzar E. A. E. Albadri, Hanem M. Awad, Eman S. Nossier and Wael A. El‐Sayed

ChemistrySelect, 2025, 10
DOI: 10.1002/slct.202404887

New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity

Hebat-Allah S. Abbas, Eman S. Nossier, May A. El-Manawaty and Mohamed N. El-Bayaa

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-62864-9

New pyrano-pyridine conjugates as potential anticancer agents: design, synthesis and computational studies

Aladdin M. Srour, Eman S. Nossier, Najla A. Altwaijry, Safeya M. Mousa, Hanem M. Awad and Heba S. A. Elzahabi

Future Medicinal Chemistry, 2024, 16, 2567
DOI: 10.1080/17568919.2024.2431475

Design, Characterization, Antimicrobial Activity, and In Silico Studies of Theinothiazoloquinazoline Derivatives Bearing Thiazinone, Tetrazole, and Triazole Moieties

Hagar S. El-Hema, Sara. M. Soliman, Wagdy El-Dougdoug, Mohamed H. M. Ahmed, Abdelmotaal Abdelmajeid, Eman S. Nossier, Modather F. Hussein, Ashtar A. Alrayes, Mariam Hassan, Noha A. Ahmed, Amr Sabry and Adel A.-H. Abdel-Rahman

ACS Omega, 2025, 10, 9703
DOI: 10.1021/acsomega.4c11076

Synthesis, antitumor activity, antimicrobial evaluation and molecular docking studies of some hydrazone, 1,3,4-oxadiazole, 1,2,4-triazole and pyrazole derivatives bearing nicotinoyl moiety

Abdel-Rahman Farghaly, Saleh A. Ahmed, Khatib S. Ismail, Diaa Ibrahim, Nasser Amri and Sameh Elgogary

Results in Chemistry, 2024, 7, 101474
DOI: 10.1016/j.rechem.2024.101474

Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity

Adel A.-H. Abdel-Rahman, Mohamed N. El-Bayaa, Asmaa Sobhy, Eman M. El-Ganzoury, Eman S. Nossier, Hanem M. Awad and Wael A. El-Sayed

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-73171-8

New thiazole derivatives linked to pyridine, fused pyridine, pyrimidine and thiazolopyrimidine scaffolds with potential dual anticancer and antimicrobial activities: Design, synthesis and docking simulation

Zahra M. Alamshany and Eman S. Nossier

Journal of Molecular Structure, 2024, 1316, 138973
DOI: 10.1016/j.molstruc.2024.138973

Novel Thiazolinone Derivatives: Synthesis, Biological Evaluation, and In Silico Studies

W. O. Alsulami, Z. M. Al-Amshany, N. Y. Tashkandi and R. M. El-Shishtawy

Russ J Org Chem, 2024, 60, 1705
DOI: 10.1134/S1070428024090136

Synthesis and computational studies of new pyridine, pyrazole, pyran, and pyranopyrimidine-based derivatives of potential antimicrobial activity as DNA gyrase and topoisomerase IV inhibitors

Aisha A. Alsfouk, Ismail M.M. Othman, Manal M. Anwar, Walaa A. Alshareef, Asmaa Saleh and Eman S. Nossier

Journal of Molecular Structure, 2025, 1319, 139528
DOI: 10.1016/j.molstruc.2024.139528

Selenization of Small Molecule Drugs: A New Player on the Board

Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín and Arun K. Sharma

J. Med. Chem., 2024, 67, 7759
DOI: 10.1021/acs.jmedchem.3c02426

From Lab to Target: Pyrazole, Pyrazoline and Fused Pyrazole Derivatives as Receptor Tyrosine Kinase Inhibitors in Cancer Therapy

Michael M. Sawiris, Omneya M. Khalil, Peter A. Halim and Marwa S. A. Hassan

Archiv der Pharmazie, 2025, 358
DOI: 10.1002/ardp.70061